(Q413299)

Bevacizumab (English)

17 November 2015

1 reference

Bevacizumab (English)

European Medicines Agency product number

17 November 2015

mass

149,000 dalton

1 reference

C₆₆₃₈H₁₀₁₆₀N₁₇₂₀O₂₁₀₈S₄₄

0 references

active ingredient in

Avastin

1 reference

EMEA/H/C/000582

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000582/human_med_000663.jsp

World Health Organisation international non-proprietary name

22 March 2017

bevacizumab (English)

1 reference

Bevacizumab (English)

medical condition treated

19 January 2016

rare urinary tract tumor

1 reference

2 October 2018

retinal vein occlusion

1 reference

2 October 2018

islet cell carcinoma

1 reference

non-small-cell lung carcinoma

2 October 2018

1 reference

2 October 2018

eye disease

1 reference

2 October 2018

metastatic melanoma

1 reference

2 October 2018

neuroendocrine carcinoma

1 reference

2 October 2018

colon adenocarcinoma

1 reference

2 October 2018

secondary neoplasm

1 reference

2 October 2018

peritoneum cancer

1 reference

2 October 2018

brain cancer

1 reference

2 October 2018

colon cancer

1 reference

2 October 2018

diabetic retinopathy

1 reference

2 October 2018

bladder cancer

1 reference

2 October 2018

bronchus carcinoma

1 reference

Kuhnt-Junius degeneration

2 October 2018

1 reference

2 October 2018

renal cell carcinoma

1 reference

2 October 2018

carcinoid tumor

1 reference

2 October 2018

rectum adenocarcinoma

1 reference

exudative vitreoretinopathy 1

2 October 2018

1 reference

2 October 2018

rectosigmoid cancer

1 reference

2 October 2018

macular retinal edema

1 reference

2 October 2018

fallopian tube carcinoma

1 reference

2 October 2018

anaplastic astrocytoma

1 reference

2 October 2018

kidney cancer

1 reference

2 October 2018

melanoma

1 reference

2 October 2018

cystoid macular edema

1 reference

gastrointestinal carcinoma

2 October 2018

1 reference

2 October 2018

rectum cancer

1 reference

small intestine carcinoma

2 October 2018

1 reference

low-grade serous carcinoma

2 October 2018

1 reference

https://cureourovariancancer.org/wp-content/uploads/2019/08/NCCN-ovarian.pdf

pregnancy category

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

subject has role

angiogenesis inhibitor

1 reference

Medical Subject Headings

MeSH descriptor ID

D000068258

immunological antineoplastic agent

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

Bevacizumab (English)

female reproductive toxicant

17 November 2015

1 reference

California Proposition 65 list of chemicals

19 February 2020

https://oehha.ca.gov/chemicals/bevacizumab

developmental toxicant

reason for deprecated rank

rectification

1 reference

California Proposition 65 list of chemicals

25 February 2020

https://oehha.ca.gov/chemicals/bevacizumab

essential medicine

0 references

Commons category

Bevacizumab

0 references

Identifiers

1 reference

Bevacizumab (English)

17 November 2015

1 reference

Hazardous Substances Data Bank

Bevacizumab (English)

19 January 2016

1 reference

28 October 2019

Bevacizumab (English)

10 May 2021

1 reference

Bevacizumab (English)

Guide to Pharmacology Ligand ID

17 November 2015

6771

1 reference

22 April 2020

https://www.guidetopharmacology.org/coronavirus.jsp

MeSH descriptor ID

D000068258

subject named as

Bevacizumab

1 reference

D12.776.124.486.485.114.224.060.375

Medical Subject Headings

14 March 2018

0 references

D12.776.124.790.651.114.224.060.438

0 references

D12.776.377.715.548.114.224.200.438

0 references

1 reference

26 February 2018

2 references

Bevacizumab (English)

17 November 2015

https://www.drugbank.ca/releases/latest#open-data

April 2018

1 reference

BEVACIZUMAB (English)

MedlinePlus drug identifier

19 January 2016

a607001

0 references

PatientsLikeMe treatment ID

0 references

1 reference

BEVACIZUMAB (English)

imported from Wikimedia project

19 January 2016

KEGG ID

D06409

1 reference

0 references

0 references

electronic Essential Medicines List medicine ID

238

1 reference

https://list.essentialmeds.org/medicines/238

eEML - Electronic Essential Medicines List (English)

Encyclopædia Britannica Online ID

23 October 2021

topic/bevacizumab

subject named as

bevacizumab

0 references

1 reference

28 October 2013

Microsoft Academic ID

2777802072

0 references

2910640057

0 references

New York Times topic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Quora topic ID

Bevacizumab

0 references

ScienceDirect topic ID

agricultural-and-biological-sciences/bevacizumab

0 references

biochemistry-genetics-and-molecular-biology/bevacizumab

0 references

immunology-and-microbiology/bevacizumab

0 references

medicine-and-dentistry/bevacizumab

0 references

nursing-and-health-professions/bevacizumab

0 references

pharmacology-toxicology-and-pharmaceutical-science/bevacizumab

0 references

UK Parliament thesaurus ID

433902

subject named as

Bevacizumab

0 references

UMLS CUI

C0796392

1 reference

WikiUMLS: Aligning UMLS to Wikipedia via Cross-lingual Neural Ranking

0 references

bevasitsumabi

bevacizumab

1 reference

YSO-Wikidata mapping project